Skip to content

Halogenated Disinfectants Inhibit Human and Rat 17β-Hydroxysteroid Dehydrogenase 1 Activity and Disrupt Estradiol Synthesis: Implications for Endocrine Disruption.

Oct 2026 · Chemico-Biological Interactions · pp. 112383 · 0 citations · 45 references
Medicine

Abstract

Halogenated disinfectants are widely used in medical, household, and industrial settings, but their inhibitory effects on 17β-hydroxysteroid dehydrogenase 1 (17β-HSD1), a key enzyme catalyzing estrone-to-estradiol (E2) conversion, remain unclear. We evaluated nine compounds for inhibition of human placental and rat ovarian 17β-HSD1 using enzymatic assays, kinetic analysis, BeWo cell E2 production assays, 3D quantitative structure-activity relationship (3D-QSAR), molecular docking, molecular dynamicssimulations (MDS), absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction, and network toxicology. Six compounds inhibited human 17β-HSD1, with half-maximal inhibitory concentration (IC50) values of 0.78-14.90 μM; potency followed hexachlorophene > bithionol > bromochlorophene > fenticlor > dichlorophene > chlorophene. Rat 17β-HSD1 was inhibited by these six compounds and by triclosan, with IC50 values of 6.13-54.77 μM. Kinetic analysis indicated mainly mixed/noncompetitive inhibition. In BeWo cells, fenticlor decreased E2 production at ≥ 1 μM, dichlorophene at 10 and 20 μM, and bromochlorophene and hexachlorophene at 20 μM, whereas chlorophene and bithionol were inactive up to 20 μM. The 3D-QSAR model and descriptor analysis suggested associations of inhibition with hydrophobicity, aromatic features, molecular size and halogenation. Docking and 100-ns MDS supported stable binding of active compounds near the nicotinamide adenine dinucleotide phosphate (NADPH)-binding region, particularly for hexachlorophene. Network toxicology placed HSD17B1, which encodes 17β-HSD1, within preeclampsia-related estrogen and steroidogenic pathways. These findings indicate that halogenated disinfectants may disrupt estrogen homeostasis through direct 17β-HSD1 inhibition and warrant further evaluation for reproductive and placental endocrine toxicity.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.